JavaScript is off. Please enable to view full site.

Novavax COVID-19 vaccine U.S. trial participants count as fully vaccinated two weeks after dosing -CDC

Novavax COVID-19 vaccine U.S. trial participants count as fully vaccinated two weeks after dosing -CDC

Tuesday, August 31, 2021, 08:03 GMT+7
Novavax COVID-19 vaccine U.S. trial participants count as fully vaccinated two weeks after dosing -CDC
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. Photo: Reuters

Participants in Novavax Inc's late-stage COVID-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease Control and Prevention said on Monday.

The CDC said the guidance does not imply an endorsement of the shot, which has not yet been authorized for use in the United States.

Novavax expects to file for U.S. emergency use authorization in the fourth quarter of 2021. 

The guidance offers clarity to participants in U.S. clinical vaccine trials at a time when more employers around the United States are mandating that staff get vaccinated against COVID-19.

Reuters

More

Read more

;

Photos

VIDEOS

‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Latest news